Pulse Biosciences (PLSE) Finished Goods (2021 - 2022)

Pulse Biosciences (PLSE) recorded quarterly Finished Goods of $750000.0 in Q3 2022, down 71.0% quarter-over-quarter from $2.6 million in Q2 2022, and down 55.91% on a YoY basis from $1.7 million in Q3 2021.

Pulse Biosciences (PLSE) Finished Goods (2021 - 2022) Analysis & Trends

Pulse Biosciences' Finished Goods history runs 2 years deep, the most recent figure standing at $750000.0 for Q3 2022.

  • In Q3 2022, Finished Goods fell 55.91% year-over-year to $750000.0; the TTM figure through Sep 2022 stood at $750000.0 (down 55.91% YoY), while the FY2021 annual figure was $2.4 million, changed N/A from the prior year.
  • Finished Goods was $750000.0 for Q3 2022 at Pulse Biosciences, down from $2.6 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $2.7 million in Q1 2022 to a low of $750000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Pulse Biosciences 1.68 Bn 1.68 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2022 750,000.00
Jun 30, 2022 2.59 Mn
Mar 31, 2022 2.74 Mn
Dec 31, 2021 2.44 Mn
Sep 30, 2021 1.70 Mn